Medicare Enrolled

Dr. Arnold Negrin, MD

Psychiatry · Savannah, GA
624 STEPHENSON AVE, Savannah, GA 31405
9123510325
Registered in NPPES since 2006
NPI: 1336186311 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Negrin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Negrin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Negrin

Dr. Arnold Negrin is a psychiatry specialist in Savannah, GA, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Negrin received a total of $13,027 from 39 pharmaceutical and/or device companies across 743 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Negrin is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration $13,027 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$13,027
Total received (2018-2024)
Avg $1,861/year across 7 years
Top 7% in GA for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
743
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,085
2023
$2,235
2022
$2,324
2021
$1,738
2020
$580
2019
$2,135
2018
$1,931

Payments by company (2024)

Supernus Pharmaceuticals, Inc.
$418
ABBVIE INC.
$321
Lundbeck LLC
$157
Vanda Pharmaceuticals Inc.
$140
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$139
Corium, LLC
$134
Otsuka America Pharmaceutical, Inc.
$125
IRONSHORE PHARMACEUTICALS INC.
$108
Tris Pharma Inc
$106
Axsome Therapeutics, Inc.
$92
Bausch Health US, LLC
$78
IDORSIA PHARMACEUTICALS US INC
$59
Janssen Pharmaceuticals, Inc
$56
Alkermes, Inc.
$54
Noven Therapeutics, LLC
$47
E.R. Squibb & Sons, L.L.C.
$28
Sage Therapeutics, Inc.
$22
Top 3 companies account for 43.0% of 2024 payments
All-time payments by company (2018-2024) ›
Supernus Pharmaceuticals, Inc.
$1,468
Otsuka America Pharmaceutical, Inc.
$1,007
ABBVIE INC.
$1,006
Ironshore Pharmaceuticals Inc.
$882
Allergan Inc.
$796
Vanda Pharmaceuticals Inc.
$735
Sunovion Pharmaceuticals Inc.
$625
Shire North American Group Inc
$609
Neos Therapeutics, LP
$608
Takeda Pharmaceuticals U.S.A., Inc.
$551
Axsome Therapeutics, Inc.
$469
ITI, Inc.
$457
Tris Pharma Inc
$445
Corium, LLC
$413
Bausch Health US, LLC
$411
AbbVie Inc.
$298
Janssen Pharmaceuticals, Inc
$278
Lundbeck LLC
$269
Alkermes, Inc.
$245
Teva Pharmaceuticals USA, Inc.
$184
JAZZ PHARMACEUTICALS INC.
$155
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$139
IDORSIA PHARMACEUTICALS US INC
$123
Adlon Therapeutics L.P.
$116
Allergan, Inc.
$116
IRONSHORE PHARMACEUTICALS INC.
$108
Vertical Pharmaceuticals, LLC
$97
Neurocrine Biosciences, Inc.
$68
Corium, Inc.
$56
Noven Therapeutics, LLC
$47
Neuronetics, Inc.
$46
Avanir Pharmaceuticals, Inc.
$35
Eisai Inc.
$30
E.R. Squibb & Sons, L.L.C.
$28
ARBOR PHARMACEUTICALS, INC.
$27
Sage Therapeutics, Inc.
$22
Lupin Inc.
$22
Arbor Pharmaceuticals, Inc.
$18
Rhodes Pharmaceuticals L.P.
$15
Top 3 companies account for 26.7% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ADHANSIA XR · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Aptensio XR · Auvelity · Azstarys · CAPLYTA · Cotempla XR-ODT · Dayvigo · Dyanavel XR · Evekeo ODT · FANAPT · Fanapt · HETLIOZ · Hetlioz · Horizant · INGREZZA · INVEGA SUSTENNA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · METHYLPHENIDATE 72 · MYDAYIS · NEUROSTAR TMS THERAPY · NUEDEXTA · OXTELLAR XR · QELBREE · QUVIVIQ · Qelbree · Quillichew ER · Quillivant · RELEXXII · REXULTI · SPRAVATO · SUNOSI · SUPRAX · Sunosi · TRINTELLIX · TROKENDI XR · Trintellix · VIIBRYD · VRAYLAR · VYVANSE · WELLBUTRIN XL · Xelstrym · ZURZUVAE
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a psychiatry specialist in Savannah?
Compare psychiatrists in the Savannah area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists in nearby ZIP areas
47
County median income
$69,575
Nearest hospital to ZIP centroid (approximate)
CANDLER HOSPITAL
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Negrin is a psychiatry specialist, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Negrin receive payments from pharmaceutical companies?
Yes. Dr. Negrin received a total of $13,027 from 39 companies across 743 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Negrin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Psychiatrists in Savannah
Browse psychiatrists in Savannah ranked by procedure volume and transparency data.
Highest volume
Top Psychiatrists in GA
Psychiatrists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Psychiatrists in GA
Which GA psychiatrists receive the most from drug and device companies.
By company
Supernus Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Supernus Pharmaceuticals, Inc.
By company
Otsuka America Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Otsuka America Pharmaceutical, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →